Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through the end of ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...

Pharmacists can help answer questions about eligibility requirements, participating medications, prior authorization ...

Weight Watchers said Tuesday that its Med+ platform will help eligible Medicare beneficiaries access GLP-1 weight-loss drugs through the new Medicare GLP-1 Bridge Program. The program, which runs from ...

(NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that Weight Watchers Med+ will support Medicare members seeking access to GLP-1 medications under ...